The aims of the current study were to determine the half-lethal concentration of ochratoxin A (OTA) as well as the levels of lactate dehydrogenase release and DNA fragmentation induced by OTA in primary porcine fibroblasts, and to examine the role of α-tocopherol in counteracting its toxicity. Cells showed a dose-, time- and origin-dependent (ear vs. embryo) sensitivity to ochratoxin A. Pre-incubation for 3 h with 1 nM α-tocopherol significantly (P < 0.01) reduced OTA cytotoxicity, lactate dehydrogenase release and DNA damage in both fibroblast cultures. These findings indicate that α-tocopherol supplementation may counteract short-term OTA toxicity, supporting its defensive role in the cell membrane.
References
[1]
Hussein, H.S.; Brasel, J.M. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology？2001, 167, 101–134, doi:10.1016/S0300-483X(01)00471-1. 11567776
[2]
Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res.？2007, 51 (1), 61–99, doi:10.1002/mnfr.200600137. 17195275
[3]
International Agency for Research on Cancer World Health Organization. Some Naturally Occurring Substances, Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; International Agency for Research on Cancer World Health Organization: Lyon, France, 1993; 56, pp. 26–32.
[4]
European Food Safety Authority. Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to Ochratoxin A in food. Question N° EFSA-Q-2005-154. EFSA J.？2006, 365, 1–56.
Council for Agricultural Science and Technology. Mycotoxins: Risks in Plant, Animal and Human System. Task Force Report, Council for Agricultural Science and Technology, No. 139; Council for Agricultural Science & Technology: Ames, IA, USA, 2003.
[7]
Ringot, D.; Chango, A.; Scheneider, Y.-J.; Larondelle, Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact.？2006, 159, 18–46, doi:10.1016/j.cbi.2005.10.106. 16293235
[8]
Kamp, H.G.; Eisenbrand, G.; Janzowski, C.; Kiossev, J.; Latendresse, J.R.; Schlatter, J.; Turesky, R.J. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol. Nutr. Food Res.？2005, 49 (12), 1160–1167, doi:10.1002/mnfr.200500124. 16302199
[9]
Baudrimont, I.; Ahouandjivo, R.; Creppy, E.E. Prevention of lipid peroxidation induced by ochratoxin A in Vero cells in culture by several agents. Chem. Biol. Interact.？1997, 104, 29–40, doi:10.1016/S0009-2797(97)03764-2. 9158693
[10]
Petrik, J.; Zani？-Grubisi？, T.; Barisi？, K.; Pepeljnjak, S.; Radi？, B.; Ferenci？, Z.; Cepelak, I. Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch. Toxicol.？2003, 77 (12), 685–693, doi:10.1007/s00204-003-0501-8. 13680094
[11]
Pfohl-Leszkowicz, A.; Bartsch, H.; Azémar, B.; Mohr, U.; Estéve, J.; Castegnaro, M. MESNA protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta Univ. Ser. Med. Biol.？2002, 9, 57–63.
[12]
Azzi, A.; Breyer, I.; Feher, M.; Pastori, M.; Ricciarelli, R.; Spycher., S.; Staffieri, M.; Stocker, A.; Zimmer, S.; Zingg, J.M. Specific cellular responses to alpha-tocopherol. J. Nutr.？2000, 130 (7), 1649–1652. 10867030
[13]
Baldi, A. Vitamin E in dairy cows. Liv. Prod. Sci.？2005, 98 (1–2), 117–122, doi:10.1016/j.livprodsci.2005.10.004.
[14]
Azzi, A. Molecular mechanism of α-tocopherol action. Free Rad. Biol. Med.？2007, 43, 16–21, doi:10.1016/j.freeradbiomed.2007.03.013.
[15]
Wang, X.; Quinn, P.J. Vitamin E and its function in membranes. Progr. Lipid Res.？1999, 38, 309–336, doi:10.1016/S0163-7827(99)00008-9.
[16]
Traber, M.G.; Atkinson, J. Vitamin E, antioxidant and nothing more. Free Rad. Biol. Med.？2007, 43, 4–15, doi:10.1016/j.freeradbiomed.2007.03.024. 17561088
[17]
Rimbach, G.; Minihane, A.M.; Majewicz, J.; Fischer, A.; Pallauf, J.; Virgli, F.; Weinberg, P.D. Regulation of cell signaling by vitamin E. Proc. Nutr. Soc.？2002, 61 (4), 415–425, doi:10.1079/PNS2002183. 12691170
[18]
Baldi, A.; Losio, M.N.; Cheli, F.; Rebucci, R.; Sangalli, L.; Fusi, E.; Bertasi, B.; Pavoni, E.; Carli, S.; Politis, I. Evaluation of the protective effects of α-tocopherol and retinol against ochratoxin A cytotoxicity. Brit. J. Nutr.？2004, 91, 507–512, doi:10.1079/BJN20041092.
[19]
Russo, A.; La Fauci, L.; Acquaviva, R.; Campisi, A.; Raciti, G.; Scifo, C.; Renis, M.; Galvano, G.; Vanella, A.; Galvano, F. Ochratoxin A-induced DNA damage in human fibroblast: protective effect of cyanidin 3-O-beta-d-glucoside. J. Nutr. Biochem.？2005, 16 (1), 31–37, doi:10.1016/j.jnutbio.2004.05.005. 15629238
[20]
Grosse, Y.; Chekir-Ghedira, L.; Huc, A.; Obrecht-Pflumio, S.; Dirheimer, G.; Bacha, H.; Pfohl-Leszkowicz, A. Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone. Cancer Lett.？1997, 114 (1–2), 225–229, doi:10.1016/S0304-3835(97)04669-7. 9103298
[21]
Fusi, E.; Rebucci, R.; Pecorini, C.; Rossi, L.; D’Ambrosio, F.; Baldi, A. Evaluation of the damage induced by ochratoxin A and the protective role of a-tocopherol in cultured bovine mammary epithelial cells. Vet. Res. Comm.？2008, 32 (1), 343–345, doi:10.1007/s11259-008-9144-9.
[22]
Schwerdt, G.; Holzinger, H.; Sauvant, C.; K？nigs, M.; Humpf, H.U.; Gekle, M. Long-term effects of ochratoxin A on fibrosis and cell death in human proximal tubule or fibroblast cells in primary culture. Toxicology？2007, 232 (1–2), 57–67, doi:10.1016/j.tox.2006.12.008. 17218050
[23]
Gekle, M.; Sauvant, C.; Schwerdt, G. Ochratoxin A at nanomolar concentrations: a signal modulator in renal cells. Mol. Nutr. Food Res.？2005, 49 (2), 118–130, doi:10.1002/mnfr.200400062. 15635689
[24]
O’Brien, E.; Heussner, A.H.; Dietrich, D.R. Species-, sex-, and cell type-specific effects of Ochratoxin A and B. Toxicol. Sci.？2001, 63, 256–264, doi:10.1093/toxsci/63.2.256. 11568369
[25]
Gekle, M.; Schwerdt, G.; Freudinger, R.; Mildeberger, S.; Wilflingseder, D.; Pollack, V.; Dander, M.; Schramek, H. Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J. Pharmacol. Exp. Ther.？2000, 293, 837–844. 10869383
[26]
Zeiss, C.J. The apoptosis-necrosis continuum: insights from genetically altered mice. Vet. Pathol.？2003, 40, 481–495, doi:10.1354/vp.40-5-481. 12949404
[27]
Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol.？2007, 35 (4), 495–516, doi:10.1080/01926230701320337. 17562483
[28]
Manderville, R.A.; Pfohl-Leszkowicz, A. Bioactivation and DNA adduction as a rationale for Ochratoxin A carcinogenesis. World Mycotoxin J.？2008, 1 (3), 357–367, doi:10.3920/WMJ2008.x039.
[29]
Schaaf, G.J.; Nijmeijer, S.M.; Maas, R.F.; Roestenberg, P.; de Groene, E.M.; Fink-Gremmels, J. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta？2002, 1588 (2), 149–158. 12385779
[30]
Fazzio, A.; Marillet, D.; Azzi, A. The effect of alpha-tocopherol and beta-tocopherol on proliferation, protein kinase C activity and gene expression in different cell lines. Biochem. Mol. Biol. Int.？1997, 41, 93–101. 9043639
[31]
Baldi, A.; Fusi, E.; Rebucci, R.; Pinotti, L.; Cheli, F. In vitro cytotoxicity of aflatoxin B1, M1 and ochratoxin A and protective effects of antioxidants. J. Dairy Sci.？2002, 85, 29.
[32]
Cheli, F.; Politis, I.; Rossi, L.; Fusi, E.; Baldi, A. Effects of retinoids on proliferation and plasminogen activator expression in a bovine mammary epithelial cell line. J. Dairy Res.？2003, 70, 367–372, doi:10.1017/S0022029903006496. 14649406
[33]
Sandau, K.; Pfeilschifter, J.; Brüne, B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int.？1997, 52, 378–386, doi:10.1038/ki.1997.344. 9263993
[34]
SAS. User's Guide: Statistics, Release 9.1; SAS Inst. Inc.: Cary, NC, USA, 2001.
